Safety and Pharmacokinetics of DoubleDose LopinavirRitonavir Rifampin Versus LopinavirRitonavir Daily Rifabutin for Treatment of Human Immunodeficiency VirusTuberculosis Coinfection

Simple item page
dc.citation.doi10.1093/CID/CIAB097
dc.citation.epage715
dc.citation.spage706
dc.contributor.authorMichelle A Kendall
dc.contributor.authorUmesh Lello
dc.contributor.authorCourtney V Fletcher
dc.contributor.authorXingye Xu
dc.contributor.authorA Et Al
dc.contributor.authorPrudence Ive
dc.date.accessioned2023-05-04T11:01:00Z
dc.date.available2023-05-04T11:01:00Z
dc.identifier.citationWOS
dc.identifier.issn1058-4838
dc.identifier.urihttps://hdl.handle.net/10539/35393
dc.journal.titleCLINICAL INFECTIOUS DISEASES
dc.journal.volume73
dc.titleSafety and Pharmacokinetics of DoubleDose LopinavirRitonavir Rifampin Versus LopinavirRitonavir Daily Rifabutin for Treatment of Human Immunodeficiency VirusTuberculosis Coinfection

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal.pdf
Size:
1.28 MB
Format:
Adobe Portable Document Format
Description:
Journal
Download

Collections

Academic Wits Research Outputs (All submissions)